Scotland · NHS Scotland MSAN
Zyban® (bupropion hydrochloride) 150mg prolonged release tablets
MSAN(2020)45 · Level 3 · issued 01 Jun 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Zyban® (bupropion hydrochloride) 150mg prolonged release tablets will be out of stock from | Out of stock | — |
| dependence, are available. | Available | — |
| All Champix® (varenicline tartrate) formulations remain available. Pfizer have advised they | Available | — |
| Various nicotine replacement therapies also remain available. | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.